Status:

COMPLETED

Hearing Aid Noise Reduction in Pediatric Users (Oticon Study)

Lead Sponsor:

Children's Hospital Medical Center, Cincinnati

Collaborating Sponsors:

Oticon

Conditions:

Hearing Impairment

Hearing Loss, Sensorineural

Eligibility:

All Genders

6-13 years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate the efficacy of OpenSound Navigator (OSN), a hearing aid speech-enhancement algorithm developed by Oticon, as treatment for pediatric hearing aid users. Using ...

Detailed Description

OpenSound Navigator (OSN) is a speech enhancement hearing aid algorithm developed by Oticon that utilizes an adaptive directional microphone system with an automatic gain control noise reduction progr...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • children ages 6 to 13 years
  • English as the primary home language
  • positive for bilateral symmetrical mild to moderately-severe sensorineural hearing loss
  • currently using hearing aids that were dispensed at least 18 months prior to enrollment of the study
  • negative for major cognitive handicap or developmental delay that would prevent or restrict participation, as determined by the PI or designee
  • negative for learning disability, for example attention-deficit/hyperactivity disorder, as determined by the PI or designee
  • negative for serious neurological or psychiatric disease that would prevent or restrict participation, as determined by the PI or designee
  • informed consent of parent/guardian
  • assent of participating child if aged 11 years and over
  • standard MRI inclusion criteria as set by the Cincinnati Children's Hospital Medical Center department of Radiology
  • not currently pregnant or breast feeding
  • willingness and ability of the participant and/or the participant's caregiver to comply with study requirements
  • no history of medical neglect of caregiver

Exclusion

    Key Trial Info

    Start Date :

    December 5 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    August 30 2020

    Estimated Enrollment :

    40 Patients enrolled

    Trial Details

    Trial ID

    NCT03771287

    Start Date

    December 5 2018

    End Date

    August 30 2020

    Last Update

    December 22 2020

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio, United States, 45229